Source: Arquivos de Gastroenterologia. Unidade: FM
Subjects: ADENOCARCINOMA, NEOPLASIAS GÁSTRICAS, ESTÔMAGO (PATOLOGIA), PROTEÍNAS PROTO-ONCOGÊNICAS
ABNT
LEHRBACH, Dárcio Matenhauer et al. Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions. Arquivos de Gastroenterologia, v. 46, n. 4, p. 315-320, 2009Tradução . . Disponível em: https://doi.org/10.1590/s0004-28032009000400013. Acesso em: 06 out. 2024.APA
Lehrbach, D. M., Cecconello, I., Ribeiro Jr, U., Capelozzi, V. L., Ab'Saber, A. M., & Alves, V. A. F. (2009). Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions. Arquivos de Gastroenterologia, 46( 4), 315-320. doi:10.1590/s0004-28032009000400013NLM
Lehrbach DM, Cecconello I, Ribeiro Jr U, Capelozzi VL, Ab'Saber AM, Alves VAF. Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions [Internet]. Arquivos de Gastroenterologia. 2009 ; 46( 4): 315-320.[citado 2024 out. 06 ] Available from: https://doi.org/10.1590/s0004-28032009000400013Vancouver
Lehrbach DM, Cecconello I, Ribeiro Jr U, Capelozzi VL, Ab'Saber AM, Alves VAF. Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions [Internet]. Arquivos de Gastroenterologia. 2009 ; 46( 4): 315-320.[citado 2024 out. 06 ] Available from: https://doi.org/10.1590/s0004-28032009000400013